Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AstraZeneca's potential $3 billion cancer pill wins early approval
Saturday, November 14, 2015A new lung cancer pill from AstraZeneca AZNL designed for patients whose disease has worsened after treatment with other therapies won early US approval on Friday in a boost for the British drugmaker Tagrisso also known as AZD is one of several canc...
Brasil Pharma sells money-losing unit for $12 million, seeks fresh capital
Friday, November 13, 2015Brazilian drugstore chain Brasil Pharma SA has sold a moneylosing subsidiary to a local investment firm for million reais million in an effort to return to profitability and cut debt BR Pharma as the company is known completed the sale of percent...
China rejects 11 drug applications over inadequate trial data
Friday, November 13, 2015China has signaled a tougher stance on drug quality in the countrys sprawling pharmaceuticals industry by rejecting applications for medicines with inadequate or suspect clinical data The China Food and Drug Administration CFDA said in statement po...
U.S. FDA approves Gilead's hepatitis C drug for expanded use
Friday, November 13, 2015Drugmaker Gilead Sciences Inc said on Thursday the US Food and Drug Administration had approved the expanded use of its blockbuster hepatitis C drug Harvoni The drug can now be used to treat patients with subtypes of chronic hepatitis C virus HCV an...
Germany, U.S. in hot pursuit of 'messenger' drug molecules
Friday, November 13, 2015A molecule that carries the recipe for making drugs inside body cells is exciting scientists and investors alike attracting hundreds of millions of dollars in a scramble for the next promising area of biotechnology German and US firms are leading th...
Novartis, Roche find 'outcome-based' drug pricing an elusive dream
Friday, November 13, 2015News that Novartiss heart drug Entresto cuts the risk of rehospitalization might have helped Chief Executive Joe Jimenez realize his ambition of getting insurers to pay more for treatments when they cut overall medical costs Instead Jimenez and Seve...
US court imposes temporary sales ban on Dr Reddy’s generic antacid
Thursday, November 12, 2015A US court has temporarily stopped Dr Reddys Laboratories from selling a generic version of AstraZenecas antacid Nexium in that market over allegations of trademark infringement The order of the District Court in Delaware has come on a suit filed by...
BioDuro, LLC announces merger with Formex, LLC, and New Leadership
Thursday, November 12, 2015BioDuro LLC a global CRO leader focused on preclinical chemistry biology and fully outsourced integrated drug development services for pharmaceutical partners announced the merger of its US operations with Formex LLC a leader in pharmaceutical API fo...
X-Rx announces Autotaxin Inhibitor collaboration with Gilead Sciences
Thursday, November 12, 2015XRx Inc announced that it has entered into an exclusive agreement with Gilead Sciences Inc to develop XRxs proprietary small molecule autotaxin ATX inhibitors ATX plays a key role in maintaining tissue homeostasis and is upregulated in many diseases...
Alnylam, Medicines Co cholesterol drug effective for six months
Thursday, November 12, 2015An experimental cholesterol fighter being developed by Alnylam Pharmaceuticals and The Medicines Co slashed levels of bad LDL cholesterol and remained effective for six months according to data from a small early stage study The drug called ALNPCSsc...
